Table of Contents
FORT WORTH, Texas — Clark Pharmaceuticals LLC and Ferndale Healthcare Inc. have partnered to produce over-the-counter therapeutic skin care products.
Their first product, DerMend Moisturizing Bruise Formula, is designed to address the bruising that often occurs with the mature skin of men and women over age 50.
Several additional products are already in the pipeline to serve the needs of this demographic group, which the principals of the two companies see as underserved.
“When we looked at this enormous and constantly expanding demographic group, we were surprised to see how little exists for their needs,” said Clark Pharmaceuticals president Steve Clark. “So we are committed to creating over-the-counter products that dermatologists recommend and are easy to access at local retail venues, as well as online.”
Clark has more than 40 years of industry experience and was widely credited with launching such successful skin care brands as Cetaphil and CeraVe.
He is joined at Clark Pharmaceuticals, a start-up company, by chief operating officer and chief financial officer David Bass, a 25-year industry veteran who previously held positions at Galderma Laboratories and Alcon.
“We see the OTC arena as having great importance to people over age 50,” added Ferndale Healthcare vice president Jeff Holm. “Our goal is to make life easier, not more complicated. We also want to make sure that we are not developing and distributing me-too products.
“DerMend Moisturizing Bruise Formula, for example, will find huge acceptance among a group whose skin is aging and bruises easily and very visibly.”
Ferndale Healthcare has a 116-year history of success in the fields of dermatology and colorectal disease, with such products as Locoid (divested in 2007) and Analpram.
